Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRAH

PRA Health Sciences (PRAH) Stock Price, News & Analysis

PRA Health Sciences logo

About PRA Health Sciences Stock (NASDAQ:PRAH)

Advanced Chart

Key Stats

Today's Range
$165.21
$165.21
50-Day Range
$165.21
$174.52
52-Week Range
$93.00
$175.95
Volume
57 shs
Average Volume
837,472 shs
Market Capitalization
$10.70 billion
P/E Ratio
50.52
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PRA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

PRAH Stock News Headlines

PRA Health Sciences
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
PRAH Historical Data
Western University of Health Sciences
Mercy College of Health Sciences
See More Headlines

PRAH Stock Analysis - Frequently Asked Questions

PRA Health Sciences, Inc. (NASDAQ:PRAH) announced its quarterly earnings results on Wednesday, April, 28th. The medical research company reported $1.35 EPS for the quarter, beating analysts' consensus estimates of $1.32 by $0.03. The company's revenue for the quarter was up 19.1% compared to the same quarter last year.

PRA Health Sciences (PRAH) raised $306 million in an initial public offering on Thursday, November 13th 2014. The company issued 17,000,000 shares at a price of $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that PRA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Visa (V) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
4/28/2021
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:PRAH
CIK
1613859
Fax
N/A
Employees
18,100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$3.90
Trailing P/E Ratio
50.52
Forward P/E Ratio
31.29
P/E Growth
N/A
Net Income
$197.04 million
Net Margins
6.40%
Pretax Margin
N/A
Return on Equity
20.49%
Return on Assets
7.07%

Debt

Debt-to-Equity Ratio
0.74
Current Ratio
1.21
Quick Ratio
1.21

Sales & Book Value

Annual Sales
$3.18 billion
Price / Sales
3.36
Cash Flow
$6.09 per share
Price / Cash Flow
27.11
Book Value
$23.06 per share
Price / Book
7.16

Miscellaneous

Outstanding Shares
64,795,000
Free Float
N/A
Market Cap
$10.70 billion
Optionable
Optionable
Beta
1.31

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:PRAH) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners